SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc.

SABS ·

SAB Biotherapeutics, Inc. (SABS) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for SAB Biotherapeutics, Inc. in 2026. The next earnings report is expected on November 17, 2026.

Earnings calendar

Next earnings date

17 Nov 2026

In 89 days

EPS estimate

-0.28

Revenue estimate

0

Past earnings

06 Aug 2026
EPS actual
-0.27 (+4.6%)
estimate -0.28
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 May 2026
EPS actual
-0.35 (-64.7%)
estimate -0.21
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

SAB Biotherapeutics beat consensus estimates on EPS, posting a loss per share of $0.27 versus an estimated loss of $0.283, and revenue met estimates at $0. In the prior quarter EPS missed expectations while revenue met estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. It offers SAB-142 anti-thymocyte globulin for Type 1 diabetes; SAB-176 for seasonal influenza; and SAB-301 for Middle East Respiratory Syndrome Coronavirus (MERS-COV). SAB Biotherapeutics, Inc. was incorporated in 2014 and is based in Sioux Falls, South Dakota with an additional office in Cambridge, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Samuel J. Reich
Employees
63
IPO date
25 Oct 2021
ISIN
US78397T2024
Website
sabbiotherapeutics.com

Frequently asked questions

When does SAB Biotherapeutics, Inc. (SABS) next report earnings?

SAB Biotherapeutics, Inc. (SABS) is scheduled to report earnings on November 17, 2026.

What was SAB Biotherapeutics, Inc.'s most recent earnings date?

SAB Biotherapeutics, Inc. (SABS) last reported earnings on August 6, 2026.

Where is SAB Biotherapeutics, Inc. stock listed?

SAB Biotherapeutics, Inc. (SABS) is listed on Nasdaq.